tiprankstipranks
Towa Pharmaceutical Co Ltd (JP:4553)
:4553
Japanese Market
4553
Towa Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4553 full AI Analyst Report?

Towa Pharmaceutical Co (4553) Income Statement

0 Followers

Towa Pharmaceutical Co Income Statement

Last quarter (Q4 2025), Towa Pharmaceutical Co's total revenue was ¥65.86B, an increase of 8.25% from the same quarter last year. In Q4, Towa Pharmaceutical Co's net income was ¥4.36B. See Towa Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 259.59B¥ 273.71B¥ 227.93B¥ 208.86B¥ 165.62B
Gross Profit
¥ 94.73B¥ 99.10B¥ 81.38B¥ 72.71B¥ 70.19B
Operating Expenses
¥ 71.49B¥ 76.00B¥ 63.73B¥ 67.20B¥ 51.65B
Depreciation and Amortization
¥ 20.10B¥ 22.84B¥ 17.89B¥ 19.41B¥ 10.95B
EBITDA
¥ 43.34B¥ 45.94B¥ 35.54B¥ 24.92B¥ 29.49B
Operating Income
¥ 23.24B¥ 23.10B¥ 17.65B¥ 5.51B¥ 18.54B
Other Income/Expenses
¥ 3.09B¥ -9.94B¥ 6.81B¥ -910.00M¥ 3.71B
Pretax Income
¥ 26.33B¥ 13.16B¥ 24.46B¥ 4.61B¥ 22.25B
Net Income
¥ 18.99B¥ 5.25B¥ 16.17B¥ 2.20B¥ 15.91B
Per Share Metrics
Basic EPS
¥ 385.70¥ 106.65¥ 328.58¥ 44.72¥ 323.35
Diluted EPS
¥ 385.70¥ 106.65¥ 328.58¥ 43.72¥ 316.19
Weighted Average Shares Outstanding
 49.23M 49.23M 49.22M 49.22M 49.22M
Weighted Average Shares Outstanding (Diluted)
 49.23M 49.23M 49.22M 50.34M 50.33M
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History